PRESENT STATUS OF MEASLES AND RUBELLA IMMUNIZATION IN THE UNITED STATES: A MEDICAL PROGRESS REPORT.KRUGMAN S.1977; J. PEDIATR.; U.S.A.; DA. 1977; VOL. 90; NO 1; PP. 1-12; BIBL. 1 P. 1/2Article

EFFECT OF HUMAN IMMUNE SERUM GLOBULIN ON INFECTIVITY OF HEPATITIS A VIRUS.KRUGMAN S.1976; J. INFECT. DIS.; U.S.A.; DA. 1976; VOL. 134; NO 1; PP. 70-74; BIBL. 5 REF.Article

THE NEWLY LICENSED HEPATITIS B VACCINE: CHARACTERISTICS AND INDICATIONS FOR USEKRUGMAN S.1982; JAMA, J. AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1982; VOL. 247; NO 14; PP. 2012-2015; BIBL. 15 REF.Article

THE PREVENTION OF VIRAL HEPATITIS.KRUGMAN S.1976; ANN. CLIN. RES.; FINL.; DA. 1976; VOL. 8; NO 3; PP. 216-220; BIBL. 26 REF.Article

Hepatitis B protection stymied by fear of AIDS?KRUGMAN, S.Dialysis & transplantation. 1984, Vol 13, Num 8, issn 0090-2934, 532Article

Worldwide strategy to control hepatitis BKRUGMAN, S.The Journal of infection. 1983, Vol 7, pp 105-106, issn 0163-4453, suppl. 1Article

VIRAL HEPATITIS, TYPEB (MS-2-STRAIN). FURTHER OBSERVATIONS ON NATURAL HISTORY AND PREVENTION = HEPATITE VIRALE DU TYPEB (SOUCHE MS-2) OBSERVATIONS PLUS COMPLETES SUR L'EVOLUTION ET LA PREVENTIONKRUGMAN S; GILES JP.1973; NEW ENGL. J. MED.; U.S.A.; DA. 1973; VOL. 288; NO 15; PP. 755-760; BIBL. 16REF.Serial Issue

RUBELLA IMMUNIZATION: A FIVE-YEAR PROGRESS REPORT = IMMUNISATION CONTRE LA RUBEOLE: RAPPORT SUR CINQ ANS. PROGRES ACCOMPLISKRUGMAN S; KATZ SL.1974; NEW ENGL. J. MED.; U.S.A.; DA. 1974; VOL. 290; NO 24; PP. 1375-1376; BIBL. 2REF.Article

VIRAL HEPATITIS, TYPE A = HEPATITE VIRALE DE TYPE A. IDENTIFICATION PAR IMMUNOADHERENCE ET FIXATION DU COMPLEMENTKRUGMAN S; FRIEDMAN H; LATTIMER C et al.1975; NEW ENGL. J. MED.; U.S.A.; DA. 1975; VOL. 292; NO 22; PP. 1141-1143; BIBL. 22REF.Article

SENSITIVITY OF SERUM BILE ACID ASSAY FOR DETECTION OF LIVER DAMAGE IN VIRAL HEPATITIS TYPE B. PROSPECTIVE STUDY IN FIVE PATIENTS = SENSIBILITE D'UN DOSAGE D'ACIDES BILIAIRES SERIQUES DANS LA DETECTION DE L'ATTEINTE HEPATIQUE AU COURS DE L'HEPATITE VIRALE DE TYPE B. ETUDE CHEZ CINQ PATIENTSHOFMANN AF; KORMAN MG; KRUGMAN S et al.1974; AMER. J. DIGEST. DIS.; U.S.A.; DA. 1974; VOL. 19; NO 10; PP. 908-910; BIBL. 15REF.Article

Forest genebics and foreign policyKRUGMAN, S. L.1985, Vol 59, Num 4, pp 529-539Article

HEPATITIS A AND B: SEROLOGIC SURVEY OF VARIOUS POPULATION GROUPSKRUGMAN S; FRIEDMAN H; LATTIMER C et al.1978; AMER. J. MED. SCI.; USA; DA. 1978; VOL. 275; NO 3; PP. 249-255; BIBL. 12 REF.Article

SENSITIVE NEUTRALIZATION TEST FOR RUBELLA ANTIBODYSATO H; ALBRECHT P; KRUGMAN S et al.1979; J. CLIN. MICROBIOL.; USA; DA. 1979; VOL. 9; NO 2; PP. 259-265; BIBL. 20 REF.Article

COMPARISON OF SEROLOGICAL TESTS FOR ANTIBODY TO HEPATITIS A ANTIGEN, USING CODED SPECIMENS FROM INDIVIDUALS INFECTED WITH THE MS-1 STRAIN OF HEPATITIS A VIRUS.DIENSTAG JL; KRUGMAN S; WONG DC et al.1976; INFECT. AND IMMUN.; U.S.A.; DA. 1976; VOL. 14; NO 4; PP. 1000-1003; BIBL. 13 REF.Article

PERSISTENCE OF MATERNAL ANTIBODY IN INFANTS BEYOND 12 MONTHS: MECHANISM OF MEASLES VACCINE FAILURE.ALBRECHT P; ENNIS FA; SALTZMAN EJ et al.1977; J. PEDIATR.; U.S.A.; DA. 1977; VOL. 91; NO 6; PP. 715-718; BIBL. 9 REF.Article

VIRAL HEPATITIS, TYPE B: STUDIES ON NATURAL HISTORY AND PREVENTION RE-EXAMINEDKRUGMAN S; OVERBY LR; MUSHAHWAR IK et al.1979; NEW ENGL. J. MED.; USA; DA. 1979; VOL. 300; NO 3; PP. 101-106; BIBL. 23 REF.Article

Infectious hepatitis: evidence for two distinctive clinical, epidemiological, and immunological types of infectionKRUGMAN, S; GILES, J. P; HAMMOND, J et al.JAMA, the journal of the American Medical Association. 1984, Vol 252, Num 3, pp 393-401, issn 0098-7484Article

International symposium on prevention of congenital rubella infection, Washington DC March 13-15, 1984BURKE, J. P; HINMAN, A. R; KRUGMAN, S et al.Reviews of infectious diseases. 1985, Vol 7, issn 0162-0886, 215 p., suppl. 1Conference Proceedings

COMPARISON OF SAFETY AND IMMUNOGENICITY OF ADW AND AYW HEPATITIS B VACCINESPAPAEVANGELOU GJ; VISSOULIS CG; ROUMELIOTOU KARAYANNIS AJ et al.1982; J. MED. VIROL.; ISSN 0146-6615; USA; DA. 1982; VOL. 9; NO 3; PP. 231-236; BIBL. 11 REF.Article

Inactivated hepatitis A vaccine : a safety and immunogenicity study in health professionalsSANDMAN, L; DAVIDSON, M; KRUGMAN, S et al.The Journal of infectious diseases. 1995, Vol 171, pp S50-S52, issn 0022-1899, SUP1Conference Paper

Reduction of the dose of hepatitis B vaccinePAPAEVANGELOU, G; ROUMELIOTOU-KARAYANNIS, A; VISSOULIS, C et al.The Journal of infection. 1983, Vol 7, pp 69-70, issn 0163-4453, suppl. 1Article

Immunogenicity of a five-microgram dose of hepatitis B vaccinePAPAEVANGELOU, G; ROUMELIOTOU-KARAYANNIS, A; VISSOULIS, C et al.Journal of medical virology. 1985, Vol 15, Num 1, pp 65-69, issn 0146-6615Article

Low-dose vaccination against hepatitis B in children: one-year follow-upMILNE, A; DIMITRAKAKIS, M; CAMPBELL, C et al.Journal of medical virology. 1987, Vol 22, Num 4, pp 387-392, issn 0146-6615Article

Identification of a unique form of protein C in the ovine fetus : developmentally linked transition to the adult formMANCO-JOHNSON, M. J; SPEDALE, S; PETERS, M et al.Pediatric research. 1995, Vol 37, Num 3, pp 365-372, issn 0031-3998Article

Developpement, sécurité et immunogénicité du vaccin contre l'hépatite A = Hepatitis A : Development, Safety and ImmunogenicityPEETERMANS, J; BINN, L. N; MARGOLIS, H. S et al.Médecine et chirurgie digestives (Paris). 1992, Vol 21, Num 2, pp 8-13, issn 0047-6412, NSConference Paper